Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
CURRENT TOPICS IN TARDIVE-DYSKINESIA IN JAPAN
Autore:
INADA T; YAGI G;
Indirizzi:
NATL INST MENTAL HLTH,NATL CTR NEUROL & PSYCHIAT,1-7-3 KOHNODAI CHIBA272 JAPAN KEIO UNIV,SCH MED,DEPT NEUROPSYCHIAT TOKYO JAPAN
Titolo Testata:
PSYCHIATRY AND CLINICAL NEUROSCIENCES
fascicolo: 5-6, volume: 49, anno: 1995,
pagine: 239 - 244
SICI:
1323-1316(1995)49:5-6<239:CTITIJ>2.0.ZU;2-J
Fonte:
ISI
Lingua:
ENG
Soggetto:
VITAMIN-E;
Keywords:
EPIDEMIOLOGY; EXTRAPYRAMIDAL SYMPTOMS; NEUROLEPTICS; PREVENTION; TARDIVE DYSKINESIA; TREATMENT;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Science Citation Index Expanded
Science Citation Index Expanded
Citazioni:
42
Recensione:
Indirizzi per estratti:
Citazione:
T. Inada e G. Yagi, "CURRENT TOPICS IN TARDIVE-DYSKINESIA IN JAPAN", PSYCHIATRY AND CLINICAL NEUROSCIENCES, 49(5-6), 1995, pp. 239-244

Abstract

This article reviews current topics in tardive dyskinesia (TD), a movement disorder associated with the prolonged use of neuroleptic agents, especially therapeutic and preventive strategies which have been or are now being studied in Japan. Tardive dyskinesia has become a major problem in the clinical psychiatric field since the early 1970s in Japan, lagging behind Western countries by more than 10 years. The average prevalence rate of TD has been estimated as 7.7% in Japan, while it has been reported in the English literature at around 15 to 20%. Clinical trials of treatments for TD have been or are now being performed in Japan with a number of novel compounds, such as ceruletide, meclofenoxate, and rolipram; however, no effective treatment has yet been established and measures to prevent TD have therefore been emphasized. These include (i) the development of new antipsychotic drugs which are free from TD, (ii) the identification of risk factors from prospective longitudinal studies, and (iii) the investigation of genetic variationsthat could act as a marker to identify especially vulnerable patientswithin the whole population of patients who need neuroleptic therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/01/20 alle ore 21:39:54